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Abstract 
BACKGROUND: The identification of an objective evaluation of frailty capable of 
predicting adverse outcomes in Alzheimer’s disease (AD) is increasingly discussed. The 
purpose of this study was to investigate whether the Frailty Index (FI) predicts hospitalization, 
institutionalization and mortality in AD patients.  
METHODS: Prospective multicenter cohort study (follow-up=2 years), including 
1,191 subjects with AD. The outcomes of interest were incident hospitalization, 
institutionalization, and mortality. The FI was calculated as the ratio of actual to thirty 
potential deficits, i.e. deficits presented by the participant divided by 30. Severity of dementia 
was assessed using the Clinical Dementia Rating (CDR) score. Cox proportional hazard 
models were performed.  
RESULTS: Mean age of the study sample was 76.2 (standard deviation=7.6) years 
old. A quadratic relationship of the FI with age was reported at baseline (R2=0.045, p<0.001). 
The FI showed a statistically significant association with mortality (age- and gender-adjusted 
HR=1.019, 95%CI=1.002-1.037, p=0.031) and hospitalization (age- and gender-adjusted 
HR=1.017, 95%CI=1.006-1.029, p=0.004), and a borderline significance with 
institutionalization. When the CDR score was simultaneously included in the age- and gender-
adjusted models, the FI confirmed its predictive capacity for hospitalization (HR=1.019, 
95%CI=1.006-1.032, p=0.004), whereas the CDR score was the strongest predictor for 
mortality (HR=1.922, 95%CI=1.256-2.941, p=0.003) and institutionalization (HR=1.955, 
95%CI=1.427-2.679, p<0.001).  
CONCLUSIONS: The FI is a robust predictor of adverse outcomes even after the 
stage of the underlying dementia is considered. Future work should evaluate the clinical 
implementation of the FI in the assessment of demented individuals in order to improve the 
personalization of care.   
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Background  
Population aging is leading to a considerable increase of age-related detrimental 
conditions, such as dependence and disability1. In this context, frailty has attracted a 
significant and increasing scientific interest2, because it is considered as a promising 
opportunity to quit the obsolete chronological criterion of age in the clinical decision process. 
Frailty is a multidimensional syndrome characterized by decreased reserves and 
diminished resistance to stressors due to the cumulative declines of multiple physiological 
systems3, 4. Among the most commonly used operational definitions of frailty, the model 
proposed by Rockwood and colleagues (the so-called “Frailty Index”, FI)5.  
The FI is founded on the theoretical concept that frailty is resulting from the 
arithmetical accumulation of deficits occurring with aging. Its operationalization takes into 
account clinical signs, symptoms, diseases, disabilities, psychosocial risk factors, and geriatric 
syndromes, resulting in a score which has shown to be strongly associated with negative 
health-related outcomes (e.g., hospitalization, institutionalization, and death) in community-
dwelling older persons6. 
The FI has been indicated as a marker of biological aging. Moreover, its internal 
structure allows a better discrimination of the risk because resembling a continuous variable 7. 
This implies that the FI is more sensible than other instruments at perceiving subtle variations 
of the health status. In other words, it allows to differentiate individuals in a more subtle way 
and substantially reduce the risk of possible ceiling/floor effects in the assessment of 
populations7.  
Accumulating evidence supports an independent association between frailty and 
dementia8, 9. Moreover, a large body of literature shows the individual association of both 
frailty and dementia to adverse health-related outcomes in population studies10-13. However, to 
our knowledge, there are currently no population studies examining whether frailty (intended 
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as resulting from the age-related accumulation of deficits) may predict hospitalization, 
institutionalization and mortality in patients with Alzheimer’s disease (AD). We hypothesize 
that the FI (i.e., an objective measure of deficits accumulation closely reflecting the biological 
status of individuals) may provide a better estimate of the vulnerability status compared to 
measures assessing the severity of dementia (such as the Clinical Dementia Rating [CDR] 
score14) in this population. In fact, the FI may improve the discrimination of risk for negative 
outcomes among patients with same chronological age and similar stage of dementia. The 
differentiation of risk profile in complex populations (such as the one composed by AD 
patients) is crucial in order to design and implement personalized interventions.   
Thus, the primary aim of the present study was to examine whether the FI predicts 
incident hospitalizations, institutionalization, and mortality in a large sample of AD patients. 
The secondary aim was to simultaneously test the capacity of the FI and the severity of 
dementia (assessed by the Clinical Dementia Rating [CDR] score) in the prediction of 
negative health-related events in AD. 
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Methods 
Participants and study design 
Data are from the Impact of Cholinergic Treatment USe (ICTUS) study, which has 
been previously described elsewhere15. Briefly, the ICTUS study is a prospective multicenter 
cohort study aimed at evaluating the clinical course, treatment outcomes, and socioeconomic 
impact of AD in Europe. It involved 29 participating centers from 12 European countries, all 
members of the European Alzheimer Disease Consortium (EADC), a network of clinical and 
research institutions specialized in the diagnosis and treatment of AD.  
The inclusion of participants in ICTUS was based on the following criteria: 1) 
diagnosis of probable AD according to the National Institute of Neurological and 
Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders 
Association (NINCDS-ADRDA) criteria; 2) MMSE score ranging from 10 to 2616; 3) living 
in the community with a well-identified informal caregiver; 4) absence of known conditions 
reducing to less than 2 years the patient’s life expectancy; 5) ability to sign an informed 
consent.  
The study was approved by the Ethics Committee of the Toulouse University Hospital 
(coordinating center) and at individual centers by local or national ethical committees. All the 
study participants signed informed consent. 
Overall, a total of 1,375 patients were recruited in the ICTUS study. After the baseline 
assessment (conducted between February 2003 and July 2005), participants were followed up 
over 2 years with mid-term re-evaluations every 6 months. At baseline and each follow-up 
visit, a comprehensive clinical and neuropsychological assessment was performed.  
The present analyses were performed in 1,191 subjects after exclusion of 184 subjects 
having missing values for the outcomes and/or the predictor of interest. Participants excluded 
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from the present analyses tended to be frailer and present more outcomes than those included 
in the analytical sample. 
 
Outcomes 
In the present study, the outcomes of interest were incident hospitalization, 
institutionalization, and mortality. Data on the three outcomes were self-reported provided by 
the caregiver and collected at each 6 month visit in the study center.  
The institutionalization (in any long-term care facility) and mortality outcomes were 
assessed considering the entire two-year period of follow-up in order to maximize the number 
of events. Differently, the definition of incident hospitalization events was censored to the 
first year of follow-up in order to better render the FI closer to the participant’s clinical status 
and avoid the inference of unforeseeable (and clinically unrelated) events (potentially 
justifying a long-term hospitalization). It is also worth to be mentioned that the exploration of 
short-term hospitalizations may provide a stronger clinical relevance to the study results 
because more directly affecting the immediate planning of interventions following an eventual 
FI assessment. This approach was previously used in the literature when exploring such 
heterogeneous outcome17, 18.  
 
Independent variable of interest 
The FI was generated taking advantage of the ICTUS data coming from the 
comprehensive assessment of the participants' health status performed at the baseline visit. 
Overall, 30 variables were included in the construction of the FI (Table 1). All the items 
considered for computing the FI were coded as dichotomous variables, where a value of 0 
indicates the absence of the deficit and a value of 1 its presence. The FI was computed by 
calculating the ratio between the number of deficits presented by the participant and the total 
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number of considered items (i.e., 30). Therefore, the FI can range from a score of 0 (no deficit 
is present) to 1 (all deficits are present). It has been previously reported that an index 
composed by a minimum of 30 variables is sufficiently robust to ensure an accurate 
computation of the subject's deficit accumulation19, 20. Although the FI was designed to be 
used as a continuous variable, it has sometimes been categorized for providing it more clinical 
relevance. In the present analyses, results are provided for the FI as a continuous variable as 
well as after its categorization (using the previously adopted 0.25 cut-point)21. 
In the present study, secondary analyses were specifically aimed at comparing the 
predictive capacity of the FI when the stage of dementia is simultaneously taken into account. 
In this context, the CDR score assessed at the baseline visit was used to measure the severity 
of dementia. The CDR scale is an instrument measuring the residual functional capacities of 
the individual in relationship with his/her cognitive abilities along five levels of impairment 
(rated as 0, 0.5, 1, 2 or 3). The rating is generated by the evaluation of six different domains: 
memory, orientation, judgment and problem solving, community affairs, home and hobbies, 
and personal care. Global CDR calculated using the algorithm proposed by Morris14 ranges 
from 0 (no dementia) to 3 (severe dementia). None of the patients in the ICTUS study 
presented a CDR score equal to 0 due to the eligibility criteria applied to the enrollment of 
participants. 
 
Other variables 
Socio-demographic information (age, gender, education), clinical factors (self-reported 
diagnosis of diabetes, hypertension, ischemic heart disease, stroke, and seizures), and 
cognitive and functional data recorded at the baseline assessment were used for describing the 
study sample.  
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Statistical analysis 
The relationship between the FI and age was first tested using the curve estimation 
option in SPSS to obtain a regression plot and estimated R squared (R2) value at baseline. Cox 
proportional hazard models were performed to study the relationship between the FI (both as 
continuous and categorical variable) with the outcomes of interest. Results are presented as 
hazard ratios (HR) and 95% confidence intervals (95%CI). The time variable for the subjects 
who died was censored at the date of death. For the subjects that were hospitalized the time 
variable was censored at the date of the first event occurred during the follow-up. Similarly, 
for the subjects that were institutionalized, the time variable was censored at the date of entry 
in the long-term setting. For those who did not experience the studied outcomes, the time 
variable was censored at the last contact date.  
In secondary analyses, Cox proportional hazard models were also performed to 
simultaneously test the FI and the CDR score in the prediction of the outcomes of interest. 
Survival curves for the relationship between the dichotomous variable of frailty were 
conducted for each of the three outcomes.  
Statistical significance was set at a p value lower than 0.05. All statistical analyses 
were performed using SPSS statistical software version 18.0.0 (IBM Corp, New York). 
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Results  
The main characteristics of the study sample (n=1,191) at the baseline assessment are 
presented in Table 2. Mean age of the population was 76.2 (standard deviation, SD=7.6) 
years. Women (63.8%) were more prevalent than men (36.2%). The mean FI was 0.21 
(SD=0.12), ranging between 0 and 0.63. More than half of the sample (n=783, 65.7%) was 
not frail (FI<0.25), whereas 408 (34.3%) patients were frail (FI≥0.25). Among the 1,191 
participants, 77 and 134 participants died and were institutionalized during the two-year 
follow-up, respectively. During the first year of follow-up, 185 incident hospitalization events 
were reported. 
Figure 1 illustrates the quadratic relationship of the accumulation of deficits and age 
at baseline (R2=0.045, p<0.001).  
The survival curves for the relationship between the dichotomous FI variable and 
mortality and hospitalization, and institutionalization (p values for log rank <0.001, 0.003 and 
0.010) are shown in Figure 2 (Panels A, B, C), respectively. 
The relationships of the FI with the studied outcomes are presented in Table 3. In both 
unadjusted and adjusted models, the FI showed a statistically significant association with 
mortality and hospitalization, and a borderline significance with institutionalization events. 
For example, considering that the FI (in percentage) is composed by 30 items, the presence of 
each additional deficit at the FI represents a >6% higher risk of mortality (HR 1.019), 
independently of age and gender. Consistently, frail individuals presented a higher risk for the 
three outcomes compared to non-frail. 
Secondary analyses were also conducted to simultaneously test the FI and the CDR 
score (Spearman’s r=0.4; p<0.001) in the prediction of the outcomes of interest (Table 3). In 
both the unadjusted and adjusted models, the severity of dementia was a stronger predictor of 
mortality and institutionalization compared to the FI. In particular, after adjustment for age 
11 
 
and gender, participants with higher CDR score presented an almost two-fold higher risk of 
mortality (HR=1.922, 95%CI=1.256-2.941, p=0.003) and institutionalization (HR=1.955, 
95%CI=1.427-2.679, p<0.001), respectively. On the other hand, each additional deficit at the 
FI was significantly associated with about 6% higher risk of hospitalization (HR=1.019, 
95%CI=1.006-1.032, p=0.004), independently of CDR. 
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Discussion 
In the present study, we evaluated the predictive capacity of the FI on incident 
hospitalization, institutionalization, and mortality in a large cohort of AD patients. Our 
findings show that the FI significantly predicts mortality and hospitalization, and tends to 
predict institutionalization events in AD patients. To take these findings further, this study 
also explored which between the accumulation of deficits and the severity of dementia was 
more predictive of adverse health-related outcomes in this population. The accumulation of 
deficits was particularly predictive of hospitalization, even when the severity of dementia was 
simultaneously considered in the adjusted models. On the other hand, the CDR score seemed 
a better independent predictor of mortality and institutionalization than the FI. 
Our results showed a quadratic relationship existing between age and FI. Such finding 
is consistent with previous studies conducted in different populations and settings12, 22, 23, and 
extends the previous limited evidence existing for patients with AD24. Our findings confirm 
the robustness of this instrument for the identification of individuals at increased risk of 
adverse health-related outcomes. As previous studies demonstrated, the FI is strongly 
associated with hospitalization25, 26, institutionalization12, 27, 28 and mortality 11, 29-31 in different 
clinical settings. The FI may indeed represent a promising tool for following and monitoring 
the health (or vulnerability) modifications of the older persons also in patients with dementia. 
This is done by providing an objective assessment of their biological age (or frailty). In this 
context, it is noteworthy that the predictive value of the FI resides in its relative order rather 
than in its precise value. In fact, previous studies computing indexes focused on specific 
conditions and/or partial aspects of the individual's health status have still confirmed the 
predictive capacity of the approach when the relative weight (and not the absolute number) of 
the deficits was considered32. In our case, despite we might have missed some information 
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about the best deficits characterizing our sample, the predictive value of the relative model 
was not affected demonstrating its robustness. 
In our analyses, when the severity of dementia (i.e., CDR score) was taken into 
account, the FI confirmed its predictive capacity for the hospitalization outcome. In contrast, 
the CDR score tended to be a stronger predictor of mortality and institutionalization than the 
FI. These findings might be explained by considering the FI as a stronger measure of the 
current biological status of the individual. Since it takes into account the accumulation of 
diseases, symptoms, disabilities, it might better capture outcomes that are more related to the 
clinical disruption of homeostasis (i.e., hospitalization). On the contrary, the severity of 
dementia may be a more “chronic” measure of the health status, reflecting the stage of the 
natural history of a specific condition (i.e., cognitive decline). Whereas it can provide an 
estimate of the length of disease (and, consequently, expected survival), it may not adequately 
perceive the heterogeneous modifications determining the frailty status. Consequently, the 
CDR score may show a stronger association than the FI with those outcomes particularly 
related to the duration of the disease (i.e., mortality and institutionalization in our case). 
Although the theoretical basis of frailty is well established3, its implementation 
(especially in the clinical practice) is still controversial. Between the two main operational 
models of frailty7, the FI seems to have a greater discriminatory capacity due to its continuous 
and comprehensive nature compared to the categorical and physical domain-centered frailty 
phenotype proposed by Fried and colleagues 33, 34. Although the frailty phenotype is 
composed by relatively easy-to-assess defining criteria, it is still unlikely that many 
individuals with dementia may complete it. For example, the cognitive impairment of the 
patient may limit his/her ability to adequately perform the physical function tests or provide 
reliable answers about signs and symptoms. Moreover, although the frailty phenotype is a 
useful screening tool for frailty, its use in the routine clinical practice, as outcome and as 
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target of interventions are strongly arguable. It is also noteworthy that the construct of the FI 
limits the floor or ceiling effects in extremely healthy or disabled populations, thus becoming 
applicable and meaningful across settings and populations. Differently from other frailty 
instruments, the FI is based on arithmetical assumptions which do not require the assessment 
of predefined criteria for measuring the frailty status. This implies that the FI (as in our case) 
can be generated a posteriori taking advantage of existing data collected for different 
purposes. 
Our study has limitations worth to be described. As mentioned, the FI computed in 
ICTUS may miss some aspects of the participants' health status which might have been 
important to better refine the frailty assessment (e.g., impaired leisure activities, social issues). 
This limitation, reducing the comprehensive approach used in generation of the ICTUS FI, 
might explain the better performance of the CDR score for the mortality and 
institutionalization outcomes. Moreover, we could not conduct analyses explaining the causes 
of the studied events. It is possible that additional details about the causes of the studied 
outcomes would have provided different results. The translation of our findings in different 
settings (e.g., hospital, nursing homes) and populations (e.g., other than AD patients) should 
first be confirmed by ad hoc analyses. 
In conclusion, the FI is a predictor of hospitalization, institutionalization and mortality 
in AD patients. The accumulation of deficits confirmed to be particularly associated with 
incident hospitalization events, independently of the stage of the underlying dementia 
condition. The need of adapting clinical care to the specific needs of the older patients 
requires instruments capable of perceiving the inner biological age of the individual. In this 
context, the FI may open interesting and promising scenarios in the field of neurodegenerative 
diseases, conditions that are particularly burdening for the person, their family, and public 
healthcare. The clinical implementation of the FI in the assessment of demented individuals 
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may improve the personalization of care by supporting the identification of an objective 
frailty status. 
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Figure 1. Frailty Index and age. 
 
Figure 2. Survival curves of the Frailty Index categories with A) mortality, B) hospitalization 
and C) institutionalization. Bold and thin lines represent frail (Frailty Index ≥0.25) and non-
frail (Frailty Index <0.25) participants, respectively. 
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Table 1. Variables included in the Frailty Index (FI)   
Diseases 
Diabetes 
Hypercholesterolemia 
Hypertension  
Ischemic heart disease  
Depression 
Stroke  
Falls 
Seizures 
Parkinsonism 
Focal signs 
 
Disabilities 
Help bathing 
Help dressing 
Help using toilet 
Help getting in/out of chair 
Incontinence 
Help eating 
Help taking medications 
 
Symptoms 
Delusions 
Hallucinations 
Agitation/aggression 
Depression/dysphoria 
Anxiety 
Elation/euphoria 
Apathy  
Disinhibition 
Irritability/lability 
Aberrant motor behaviour 
Sleep disorder 
Appetite and eating disorders 
 
Physical performance  
Impaired one-leg stand test 
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Table 2. Baseline characteristics of the study sample (n=1,191)   
  Mean (SD) or % 
Age (years) 76.2±7.6 
Gender (women)   63.8 
Body mass index (kg/m2) 25.2±4.2 
Education (years) 8.0±4.7 
  
Diabetes  11.6 
Hypertension  39.0 
Ischemic heart disease  13.2 
Stroke  8.0 
Falls  17.1 
Seizures  1.1 
Depression  24.5 
  
ADAS-Cog (points) 20.5±9.2 
MMSE (points) 20.6±3.9 
CDR score (points)  
   - 0.5 43.2 
   - 1 44.2 
   - ≥2 12.6 
  
Frailty Index  0.21±0.12 
  
ADL (/6) 5.5±0.9 
IADL (/8) 4.9±2.2 
Values are presented as means ± standard deviations (SD) or percentage 
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Table 3. Results from unadjusted and adjusted proportional hazard models testing the relationships of the FI (alone and simultaneously with the 
CDR score) for the mortality, hospitalization and institutionalization outcomes.  
 Mortality P Hospitalization  P  Institutionalization  P 
 n/N=77/1,191  n/N=185/1,191  n/N=134/1,191  
Unadjusted       
Frailty Index (continuous)* 1.023 (1.005, 1.040) 0.011 1.018 (1.006, 1.030) 0.002 1.018 (1.004, 1.032) 0.009 
       
Not frail (FI<0.25) 1  1  1  
Frail (FI≥0.25)  2.211 (1.413, 3.457) 0.001 1.557 (1.164, 2.083) 0.003 1.566 (1.112, 2.206) 0.010 
       
Frailty Index (continuous)* 1.009 (0.990, 1.028) 0.369 1.019 (1.006, 1.032) 0.003 1.003 (0.988, 1.019) 0.652 
CDR score  2.038 (1.349, 3.081) 0.001 0.929 (0.679, 1.272) 0.648 2.028 (1.486, 2.766) <0.001 
       
       
Adjusted for age, gender       
Frailty Index (continuous)* 1.019 (1.002, 1.037) 0.031 1.017 (1.006, 1.029) 0.004 1.011 (0.997, 1.025) 0.116 
       
Not frail (FI<0.25) 1  1  1  
Frail (FI≥0.25)  1.409 (0.997, 1.992) 0.052 1.525 (1.137, 2.046) 0.005 2.121 (1.352, 3.325) 0.001 
       
Frailty Index (continuous)* 1.007 (0.987, 1.027) 0.494 1.019 (1.006, 1.032) 0.004 0.998 (0.983, 1.014) 0.838 
CDR score  1.922 (1.256, 2.941) 0.003 0.913 (0.664, 1.254) 0.573 1.955 (1.427, 2.679) <0.001 
Results are presented as HR and 95%CI. 
* The Frailty Index (continuous variable) is included in the models as percentage in order to facilitate the reading of the results. 
FI: Frailty Index; CDR score: Clinical Dementia Rating score; n/N: number of events/total study sample 
 
